NEU 0.35% $19.97 neuren pharmaceuticals limited

Cod, I think that's a safe assumption. The ann last year was 2nd...

  1. 2,622 Posts.
    lightbulb Created with Sketch. 423
    Cod, I think that's a safe assumption.

    The ann last year was 2nd March, but the FXS trial was announced 7 Dec as opposed to 12 Nov for Rett. So you'd guess somewhere between now and April we'd get an ann if successful.

    April's getting more interesting every day.

    Frankly I'm assuming not and that the FXS timeline follows the Rett one but delayed by a year.

    On the other hand, BT notwithstanding, it took 6 months to meet with the FDA to plan the next trial and it's likely the silence on FXS is just the wheels moving very slowly in the background.
    Last edited by ajostu: 10/03/16
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.